UA79267C2 - Peroral composition of solid solution of poorly water-soluble active substance and process for its preparation - Google Patents

Peroral composition of solid solution of poorly water-soluble active substance and process for its preparation Download PDF

Info

Publication number
UA79267C2
UA79267C2 UA20040907457A UA20040907457A UA79267C2 UA 79267 C2 UA79267 C2 UA 79267C2 UA 20040907457 A UA20040907457 A UA 20040907457A UA 20040907457 A UA20040907457 A UA 20040907457A UA 79267 C2 UA79267 C2 UA 79267C2
Authority
UA
Ukraine
Prior art keywords
mixture
active substance
alkyl
composition
immediate
Prior art date
Application number
UA20040907457A
Other languages
English (en)
Ukrainian (uk)
Inventor
Henricus R M Gorissen
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Publication of UA79267C2 publication Critical patent/UA79267C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
UA20040907457A 2002-02-14 2003-11-02 Peroral composition of solid solution of poorly water-soluble active substance and process for its preparation UA79267C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02075623 2002-02-14
PCT/EP2003/050014 WO2003068266A1 (en) 2002-02-14 2003-02-11 Oral solid solution formulation of a poorly water-soluble active substance

Publications (1)

Publication Number Publication Date
UA79267C2 true UA79267C2 (en) 2007-06-11

Family

ID=27619166

Family Applications (1)

Application Number Title Priority Date Filing Date
UA20040907457A UA79267C2 (en) 2002-02-14 2003-11-02 Peroral composition of solid solution of poorly water-soluble active substance and process for its preparation

Country Status (24)

Country Link
US (2) US20050008697A1 (pl)
EP (1) EP1476196B1 (pl)
JP (1) JP2005517041A (pl)
KR (1) KR101014545B1 (pl)
CN (1) CN1273194C (pl)
AR (1) AR038681A1 (pl)
AT (1) ATE345817T1 (pl)
AU (1) AU2003208713B2 (pl)
BR (1) BR0307278A (pl)
CA (1) CA2472744A1 (pl)
DE (1) DE60309839T2 (pl)
DK (1) DK1476196T3 (pl)
ES (1) ES2277635T3 (pl)
HR (1) HRP20040613A2 (pl)
IL (2) IL162883A0 (pl)
MX (1) MXPA04007852A (pl)
NO (1) NO20043832L (pl)
PL (1) PL370452A1 (pl)
PT (1) PT1476196E (pl)
RU (1) RU2314811C2 (pl)
SI (1) SI1476196T1 (pl)
UA (1) UA79267C2 (pl)
WO (1) WO2003068266A1 (pl)
ZA (1) ZA200405608B (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004062692A1 (en) * 2003-01-13 2004-07-29 Solvay Pharmaceuticals B.V. Formulation of poorly water-soluble active substances
US8025899B2 (en) * 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) * 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US20050267124A1 (en) * 2004-05-14 2005-12-01 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous producing system and PDEV inhibiitors
US20060159748A1 (en) * 2004-12-23 2006-07-20 Rajesh Jain Oral immediate release formulation of a poorly water-soluble active substance
TW200633713A (en) * 2004-12-23 2006-10-01 Solvay Pharm Bv Oral immediate release formulation of a poorly water-soluble active substance
WO2007054975A1 (en) * 2005-11-08 2007-05-18 Panacea Biotec Ltd Pharmaceutical compositions for the treatment of cardiovascular and other associated disorders
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
JP2007308479A (ja) 2006-04-20 2007-11-29 Shin Etsu Chem Co Ltd 固体分散体製剤
WO2007144418A1 (en) * 2006-06-16 2007-12-21 Solvay Pharmaceuticals B.V. Oral pharmaceutical composition of a poorly water-soluble active substance
JP2009541267A (ja) * 2006-06-22 2009-11-26 ソルベイ・フアーマシユーチカルズ・ベー・ブイ 低い水溶性活性物質の経口製薬学的組成物
AU2007271088A1 (en) * 2006-07-06 2008-01-10 Ares Trading S.A. An oral pharmaceutical composition of an anilinopyrimidine, its preparation and use thereof
MX2009002335A (es) * 2006-09-01 2009-03-20 Teva Pharma Composiciones solidas de un compuesto activo receptor de calcio.
AR071375A1 (es) * 2008-04-22 2010-06-16 Solvay Pharm Gmbh Formulaciones para ingredientes farmaceuticos activos de permeabilidad deficiente, proceso de preparacion y producto
WO2010144865A2 (en) 2009-06-12 2010-12-16 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
HRP20180904T1 (hr) 2010-08-04 2018-08-24 Grünenthal GmbH Farmaceutski oblik doziranja koji sadrži 6'-fluoro-(n-metil-ili n,n-dimetil-)-4-fenil-4',9'-dihidro-3'h-spiro[cikloheksan-1,1'-pirano[3,4,b]indol]-4-amin za liječenje neuropatske boli
SI2600839T1 (en) * 2010-08-04 2018-04-30 Gruenenthal Gmbh A pharmaceutical dosage form comprising 6'-fluoro- (N-methyl- or N, N-dimethyl-4-phenyl-4 ', 9'-dihydro-3'H- spiro- (cyclohexane-1,1'- pyrano- (3,4, b) indol) -4-amine
CN107735080B (zh) * 2015-07-03 2020-10-23 浙江海正药业股份有限公司 一种人参皂苷c-k口服固体制剂及其制备方法
PL424453A1 (pl) 2018-01-31 2019-08-12 Forty-Four Pharmaceuticals Spółka Z Ograniczoną Odpowiedzialnością Sposoby zmniejszania szkodliwego działania niedoboru perfuzji narządów miąższowych przez inhibitory obojętnej endopeptydazy (NEP) i ludzkiej rozpuszczalnej endopeptydazy (hSEP)
PL424452A1 (pl) 2018-01-31 2019-08-12 Forty-Four Pharmaceuticals Spółka Z Ograniczoną Odpowiedzialnością Inhibitory obojętnej endopeptydazy (NEP) i ludzkiej rozpuszczalnej endopeptydazy (hSEP) do profilaktyki i leczenia chorób oczu
EP4487915A3 (en) * 2018-11-30 2025-03-19 ChemoCentryx, Inc. Capsule formulations
CN121532170A (zh) * 2023-07-18 2026-02-13 三亚制药株式会社 含普仑司特的药物组合物的制备方法以及通过所述制备方法制备的药物组合物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3359167A (en) * 1965-07-22 1967-12-19 Pfizer & Co C Vitamin a compositions
CU35543A1 (es) * 1980-10-09 1983-05-05 Hoffmann La Roche Prostaglandines
NZ224497A (en) * 1987-05-18 1990-04-26 Janssen Pharmaceutica Nv Pharmaceutical composition comprising flunarizine
US5281420A (en) * 1992-05-19 1994-01-25 The Procter & Gamble Company Solid dispersion compositions of tebufelone
DE19510566A1 (de) * 1995-03-23 1996-09-26 Kali Chemie Pharma Gmbh Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19638020A1 (de) * 1996-09-18 1998-03-19 Solvay Pharm Gmbh Die gastrointestinale Durchblutung fördernde Arzneimittel
ZA9710927B (en) * 1996-12-06 1998-06-15 Fujisawa Pharmaceutical Co Pharmaceutical composition.
KR20050084502A (ko) * 1997-01-30 2005-08-26 노파르티스 아게 오일을 함유하지 않은 사이클로스포린 ａ 함유 제약 조성물
US6008191A (en) * 1997-09-08 1999-12-28 Panacea Biotec Limited Pharmaceutical compositions containing cyclosporin
KR100336090B1 (ko) * 1998-06-27 2002-05-27 윤승원 오일, 지방산 또는 이들의 혼합물을 함유한 난용성 약물의 고형분산제제
DE19906310A1 (de) * 1999-02-16 2000-08-17 Solvay Pharm Gmbh Arzneimittel zur Behandlung von Bluthochdruck
DE19932555A1 (de) * 1999-07-13 2001-01-18 Solvay Pharm Gmbh Arzneimittel mit protektiver Wirkung gegen oxidativ-toxische und insbesondere gegen kardiotoxische Substanzen
US20010036959A1 (en) * 2000-04-03 2001-11-01 Gabel Rolf Dieter Carvedilol-hydrophilic solutions

Also Published As

Publication number Publication date
DK1476196T3 (da) 2007-03-05
ATE345817T1 (de) 2006-12-15
RU2314811C2 (ru) 2008-01-20
CN1273194C (zh) 2006-09-06
EP1476196A1 (en) 2004-11-17
DE60309839T2 (de) 2007-03-15
AU2003208713A1 (en) 2003-09-04
AR038681A1 (es) 2005-01-26
SI1476196T1 (sl) 2007-04-30
ES2277635T3 (es) 2007-07-16
HRP20040613A2 (en) 2005-04-30
WO2003068266A1 (en) 2003-08-21
US20110086844A1 (en) 2011-04-14
AU2003208713B2 (en) 2007-10-18
CA2472744A1 (en) 2003-08-21
NO20043832L (no) 2004-09-13
ZA200405608B (en) 2005-06-24
EP1476196B1 (en) 2006-11-22
US20050008697A1 (en) 2005-01-13
BR0307278A (pt) 2004-12-28
JP2005517041A (ja) 2005-06-09
MXPA04007852A (es) 2004-10-15
DE60309839D1 (de) 2007-01-04
IL162883A0 (en) 2005-11-20
KR101014545B1 (ko) 2011-02-16
RU2004127457A (ru) 2005-04-20
CN1633307A (zh) 2005-06-29
HK1077218A1 (en) 2006-02-10
PT1476196E (pt) 2007-02-28
KR20040085193A (ko) 2004-10-07
PL370452A1 (pl) 2005-05-30
AU2003208713B9 (en) 2003-09-04
IL162883A (en) 2009-05-04

Similar Documents

Publication Publication Date Title
RU2314811C2 (ru) Пероральная композиция твердого раствора малорастворимого в воде активного вещества
JP2002529397A5 (pl)
JP2021185139A5 (pl)
PT1345595E (pt) Formulação farmacêutica de libertação prolongada independente da força iónica
UA77736C2 (en) Pharmaceutical composition based on azetidine derivatives
AP1192A (en) Solubilized sertraline compositions.
WO2008087076A1 (en) Pharmaceutical composition of improved stability containing taxane derivatives
JP5276591B2 (ja) ピレノキシン含有二液性点眼剤
JP5624281B2 (ja) 光安定性に優れたキノロン系抗菌薬含有液体製剤
Fu et al. Preparation of fast-dissolving tablets based on mannose
JP5918894B1 (ja) ナルフラフィン塩酸塩含有カプセル製剤
JP2011026212A (ja) 保存安定性に優れ、良好な打錠性を有するフルボキサミンマレイン酸塩錠剤
Abdelaziz et al. The wetting of surface‐treated silicone impression materials by gypsum mixes containing disinfectants and modifiers
Chavda et al. Topical vaginal drug delivery system based on superporous hydrogel hybrids
Maddela et al. Formulation and Evaluation of Piroxicam Liquid FillFormulations
JPH0466531A (ja) 新規なピコスルファートナトリウム液充填硬カプセル剤
JPH02188524A (ja) ピコスルフアートナトリウム液充填硬カプセル剤
JPH0160451B2 (pl)
NZ501250A (en) Solubilized sertraline compositions
JP2017014119A (ja) 経口医薬組成物